l-carnitine treatment of chronic fatigue syndrome Polyphenols as possible alternative agents in fatigue: a review | Phytochemistry Reviews Chronic fatigue syndrome (CFS): Suggestions
Description
In the subgroup analysis based on L-carnitine dose, when the treatment dose was more than 1 g/d, fasting blood glucose, triglycerides, and high-density lipoprotein-cholesterol were significantly improved
it also encompasses the mitigation of immune-related adverse events (irAEs)
Mitochondrial pathophysiology, reactive oxygen Species, and cardiovascular diseases
Arginine:glycine amidinotransferase (AGAT) deficiency: clinical features and long term outcomes in 16 patients diagnosed worldwide
Thermo Fisher Scientific, Inc.)
KimAXuNUmeyamaKHulinAPonnySVagnozziRet alDeficiency of circulating monocytes ameliorates the progression of myxomatous valve degeneration in Marfan syndrome
